Report Description Table of Contents In 2020, the valuation of the sacral nerve stimulation market was $2.87 billion. However, as per the SMR analysts,Itwill reach up to $3.2 billion by 2028, representing a CAGR of 14.07 percent throughout 2020-2028. Sacral nerve stimulation (SNS) is a medical and electrical stimulation therapy that entails implanting a programmable stimulator under the skin, delivering low-amplitude electrical stimulation to the sacral nerve via a lead, which is commonly usedto access through the S3 foramen. SNS is a therapeutic approach for treating bladder and bowel disorders such as overactive bladder, fecal incontinence, and bowel management in patients. Sacral nerve stimulation helps to restore the critical functions of the bladder or bowel. According to the bladder and bowel community, it has been used to treat 200,000 patients worldwide. The treatment primarily aims to improve the coordination between the bladder and the brain. Moreover, sacral nerve stimulation is a highly successful and safe treatment for fecal and urinary problems. According to the Centres for Medicare and Medicaid Services, urinary incontinence affects around 13 million adults in the U.S., andwomen constitute the majority of participants. In addition, women are more likely to experience urine incontinence than men. A study published in March 2021 by SedigheBatmani et al. in the BMC Geriatrics Journal indicates that the highest prevalence of urine incontinence was recorded in older adult women in Asia (45.1 percent).According to the National Institute of Health, the general 5-year and 7-year SNM success rates were 75.1% and 69.8%, respectively. Covid-19 impact on Sacral Nerve Stimulation Market The COVID-19 outbreak negatively impacted the market, as most Non-COVID treatment services were paused to free up the healthcare centers for COVID-19-infected patients and reduce the transmission of the SARS-CoV-2 virus. The British Journal of Surgery published a report in May 2020 detailing, During COVID-19 in 2020, 28.4 million elective procedures were canceled or postponed over 12 weeks due to peak in-hospital service disruptions. Jeremy Yuen-Chun Teoh et al. conducted a global survey titled "A Global Survey on the Impact of COVID-19 on Urological Services" (2020). According to the study, the pandemic had the highest impact on outpatient clinics treating women's urinary incontinence, benign prostatic hyperplasia, infertility, benign scrotal conditions, renal stone, and bladder stone. Furthermore, during the COVID-19 pandemic, 28 percent of all outpatient clinics, 30 percent of all outpatient investigations and procedures, and 31 percent of all urological surgeries experienced a delay of more than eight weeks.Therefore, due to the circumstances mentioned above, the COVID-19 pandemic is expected to influence the market negatively. Market Drivers: Increasing number of patients for various diseases such as overactive bladder disorders, urge incontinence, etc. along with increasing investment in research and development of technological products are set to drive the market The increasing elderly populationand cases related to obesity, diabetes, hypertension, and smoking influence urine incontinence in older women tend to drive the market's growth. Hence, with the rise in the target patients in the coming years,it is highly possible to increase the demand for this market. Moreover, the market is likely to be driven by the growing geriatric population globally, increasing research investments, and technical improvements related tocreating novel medical devices over the forecasted period. The increasingoccurrence of overactive bladder disorders, urge incontinence, such as urinary tract infections, and the rising number of patients suffering from OAB and fecal incontinence are the primary drivers of market expansion. The Indian Journal of Community Medicine published an article in 2019 that says that the prevalence of urinary incontinence in postmenopausal women aged 45 to 90 years was around 26.47%. In addition, the National Center for Biotechnology Information (NCBI) stated in an article titled "Urinary Incontinence in Postmenopausal Women" (2019) that various diseases have been increasing around the world, including Parkinson's disease, diabetes, and multiple sclerosis, which may lead to an increased prevalence of urinary incontinence. Market Restraint: adverse government policies and side effects of nerve stimulation will restrain the market's growth The market's expansion is hampered by health hazards connected with nerve stimulation and adversegovernmentalpolicies. Moreover, the high costs associated with the treatment procedureswill operate as a market growth barrier. Concerns about the device's adverse and side effects will further derail the growth rate of the sacral nerve stimulation (SNS). Market Opportunity: untapped regions with greater medical needs and the growing number of elderly population around the world will be creating a number of opportunities for the market The expansion of the market is likely to be successful in untapped regions with unmet medical needs and technology improvements aimed at minimizing the associated infections. The growing senior population will open up the new business potentials for lung cancer screening programs. Urinary tract infections (UTIs) were the most prevalent outpatient infections, according to a study published in Therapeutic Advances in Urology (2019). UTIs wereexceptionally high among the elders, with 205 women aged 65 and above having UTIs, accounting for 11% of the total population investigated. These populations are likely to boost the segment's expansion by creating a demand for the therapy. Market Segmentation By Product External Implantable By Application Urge Incontinence Chronic Anal Fissure Urinary &Fecal Incontinence Others By Region North America U.S. Canada Mexico Europe Germany France Italy Switzerland U.K. Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA Based on Product: External SNS is predicted to be the fastest-growing sector over the projected period due to the rising incidence of OAB and fecal incontinence. It is mainly used to control the bladder by using external devices to send electrical impulses to the sacral nerves. Due to rising incidences of urine incontinence, pelvic discomfort, and fecal incontinence, the implantable devices segment will continue to grow considerably during the forecasted period. An implantable neurostimulator device is implanted with a needleto manage bladder functionand is performed without any surgery. Therefore, it is highly beneficial for the patients suffering from urge incontinence from this treatment. Based on Application: Over the projected period, urinary and fecal incontinence is expected to be the fastest-growing and most significant market segment. The rising number of patients with UTIs, OABs, and anal sphincter injuries is well related to this market's growth. In addition, fecal incontinence can be caused by various factors, including obstetric trauma, voiding dysfunction,Interstitial Cystitis, andfecal impaction. Therefore, the rising prevalence of urine and fecal incontinence is propelling this market forward. Regional Analysis: North Americaholds the largest Sacral Nerve Stimulation Marketshare andis expected to expand due to the growing geriatric population and the growing desire for minimally invasive operations. According to the Population Reference Bureau's "Aging in the United States,"As of 2018, there were 52 million Americans aged 65 or older. By 2060, the number is expected to reach 95 million. Also, Urinary incontinence is predicted to impact 10-13 million people in the United States, according to a Medscape article published in June 2021. Also, Constipation is very frequent in the United States, affecting people of all ages and populations. Constipation affects around 16 out of every 100 people in which 33 out of every 100 individuals are 60 years and above in age.Moreover, country-wise, functional Constipation was found lowest in Australia, followed by China, Germany, and Honduras. At the same time, South Korea possesses the most cases, followed by Turkey, the Netherlands, and Ghana. The Asia Pacific will be growing at the fastest rate from 2020 to 2028 due to the increased number of patients suffering from fecal and urine incontinence. Report Attribute Details Forecast Period 2020 - 2028 Market size value in 2020 USD 2.87 Billion Revenue forecast in 2028 USD 3.2 Billion Growth rate CAGR of approximately 14.07% Base year for estimation 2020 Historical data 2016 – 2019 Unit USD Billion, CAGR (2020 - 2028) Segmentation By Product, By Application, By Region. By Product External, Implantable. By Application Urge Incontinence, Chronic Anal Fissure, Urinary &Fecal Incontinence, Others. By Region North America, Europe, Asia Pacific, Australian Bureau of Statistics. Country Scope U.S. , Canada , France, Germany ,U.K. , China , Japan , India , South Korea, Mexico, Brazil ,U.A.E. etc. Company Usability Profiles Cyberonics, Codman & Shurtleff, Axonics Modulation Technologies, NeuroPace, Medtronic, Uroplasty, Laborie, St. Jude Medical, Synapse Biomedical, IntraPace, Boston Scientific Corporation, Nevro Corp. Pricing and purchase options Avail customized purchase options to meet your exact research needs. Competitive Analysis Key Players in the market are as follows: Cyberonics Codman & Shurtleff Axonics Modulation Technologies NeuroPace Medtronic Uroplasty Laborie St. Jude Medical Synapse Biomedical IntraPace Boston Scientific Corporation Nevro Corp. Recent Developments In February 2021, Axonics Modulation Technologies Inc. acquired privately-held Contura Ltd. and its flagship product, Bulkamid, which treatswomen's stress urinary incontinence (SUI). In September 2019, Axonics Modulation Technologies Inc. gained FDA approval for its axons sacral nerve stimulator or Axonics Sacral Neuromodulation System to treat persistent fecal incontinence. Frequently Asked Question About This Report How big is the sacral nerve stimulation market? In 2020, the valuation of the global sacral nerve stimulation market was $2.87 billion. What is the CAGR rate for the sacral nerve stimulation market over the forecasted period? The CAGR rate for the market over the forecasted periodis14.07 percent. Who are the key players operating in the sacral nerve stimulation market? The key players in the market are Cyberonics, Codman & Shurtleff, Axonics Modulation Technologies, NeuroPace, Medtronic, Uroplasty, Laborie, St. Jude Medical, Synapse Biomedical, IntraPace, Boston Scientific Corporation, Nevro Corp. Which Region has the largest sacral nerve stimulation market share? North America has the largest sacral nerve stimulation market share What do you mean by interstitial Cystitis? Interstitial Cystitis is a chronic pain disorder that can cause pressure in the bladder, pain in the bladder, and sometimes pain in the pelvis. N/A Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Sacral Nerve Stimulation Market Segmentation 1.3.2 Geographic Scope Figure 02: Sacral Nerve Stimulation Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Sacral Nerve Stimulation Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Sacral Nerve Stimulation Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Sacral Nerve Stimulation Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Sacral Nerve Stimulation Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Sacral Nerve Stimulation Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Sacral Nerve Stimulation Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Sacral Nerve Stimulation Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: External SNS to Witness Highest CAGR in Sacral Nerve Stimulation Market, By Product, During Forecast Period Figure 11: Urinary and fecal incontinence Higher CAGR in Sacral Nerve Stimulation Market for Application Segment during Forecast Period Figure 12: North America to Account for Largest Share of Global Sacral Nerve Stimulation Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 13: Sacral Nerve Stimulation Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Sacral Nerve Stimulation Market 5.2.1 Global Sacral Nerve Stimulation market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Sacral Nerve Stimulation market, by region, 2020 - 2028 (USD Million) 5.4 Product Segment Analysis 5.4.1 Global Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 5.5 Application Segment Analysis 5.5.1 Global Sacral Nerve Stimulation market, By Application, 2020 - 2028 (USD Million) 5.6 Value Chain Analysis 5.7 Market Variable Analysis 5.7.1 Market Drivers Analysis 5.7.2 Market Restraints Analysis 5.8 Business Environment Analysis Tool 5.8.1 Sacral Nerve Stimulation market PEST analysis 5.8.2 Sacral Nerve Stimulation market Porter’s analysis 5.9 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 14 Sacral Nerve Stimulation Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 15 Sacral Nerve Stimulation Market Drivers and Their Impact 6.2.2 Restraints Figure 16 Sacral Nerve Stimulation Market Restraints and Their Impact 6.2.3 Opportunities Figure 17 Sacral Nerve Stimulation Market Opportunities and Their Impact 6.2.4 Challenges Figure 18 Sacral Nerve Stimulation Market Challenges and Their Impact 6.3 Impact of Covid-19 on Sacral Nerve Stimulation Market 6.4 Value Chain Analysis Figure 19 Value Chain Analysis: Sacral Nerve Stimulation Market 6.5 Ecosystem Figure 20 Sacral Nerve Stimulation Market: Ecosystem Table 3 Sacral Nerve Stimulation Market: Ecosystem Figure 21 Revenue Shift in Sacral Nerve Stimulation Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Sacral Nerve Stimulation Market in USA in Last 9 Years Figure 22 Top 12 Companies with Highest No. of Patents in Last 9 Years Figure 23 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Sacral Nerve Stimulation Market 6.7 Trade Analysis Figure 24 Import Data for External, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Implantable, By Country, 2016–2020 (USD Thousand) Figure 25 Export Data for External, By Country, 2016–2020 (USD Thousand) Table 7 Export Data for Implantable, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Sacral Nerve Stimulation Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 9 Key Regulations: Sacral Nerve Stimulation Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 26: Key players market share of companies 7.2 Manufacturers Sacral Nerve Stimulation Manufacturing Sites, Area Served, Product Type 7.3 Sacral Nerve Stimulation Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Sacral Nerve Stimulation Market: Product Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 11 Sacral Nerve Stimulation Market, By Product, 2021–2028 (USD Million) Figure 27 Sacral Nerve Stimulation Market, By Product Figure 28 External SNS Segment to Register Highest CAGR in Sacral Nerve Stimulation Market During Forecast Period 8.3 External 8.3.1 External market, 2020 - 2028 (USD Million) Figure 29: External market, 2020 - 2028 (USD Million) 8.4 Implantable 8.4.1 Implantable market, 2020 - 2028 (USD Million) Figure 30: Implantable market, 2020 - 2028 (USD Million) Chapter 9. Global Sacral Nerve Stimulation Market: Application Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 12: Sacral Nerve Stimulation Market, By Application, 2021–2028 (USD Million) Figure 31: Sacral Nerve Stimulation Market, By Application, 2021–2028 (USD Million) Figure 32: urinary and fecal incontinence Segment to Register Highest CAGR in Sacral Nerve Stimulation Market during Forecast Period 9.3 Urge Incontinence 9.3.1 Urge Incontinence market, 2020 - 2028 (USD Million) Figure 33: Urge Incontinence market, 2020 - 2028 (USD Million) 9.4 Chronic Anal Fissure 9.4.1 Chronic Anal Fissure market, 2020 - 2028 (USD Million) Figure 34: Chronic Anal Fissure market, 2020 - 2028 (USD Million) 9.5 Urinary & Fecal Incontinence 9.5.1 Urinary & Fecal Incontinence market, 2020 - 2028 (USD Million) Figure 35: Urinary & Fecal Incontinence market, 2020 - 2028 (USD Million) 9.6 Others 9.6.1 Others market, 2020 - 2028 (USD Million) Figure 36: Others market, 2020 - 2028 (USD Million) Chapter 10. Global Sacral Nerve Stimulation Market: Regional Outlook 10.1 North America Figure 37: North America Sacral Nerve Stimulation Market, By Revenue Forecast (2020-2028) 10.1.1 North America Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Table 13: North America Sacral Nerve Stimulation Market, by Country, 2020-2028 Figure 38: North America Sacral Nerve Stimulation Market 10.1.2 North America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Table14: North America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 39: North America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.1.3 North America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Table 15: North America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 40: North America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.1.4 U.S. 10.1.4.1 U.S. Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 41: U.S. Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.1.4.2 U.S. Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 42: U.S. Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.1.5 Canada 10.1.5.1 Canada Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 43: Canada Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.1.5.2 Canada Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 44: Canada Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 45: Canada Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 46: Canada Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.2 Europe Figure 47: Europe Sacral Nerve Stimulation Market, By Revenue Forecast (2020-2028) 10.2.1 Europe Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Table 16: Europe Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Figure 48: Europe Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) 10.2.2 Europe Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Table 17: Europe Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 49: Europe Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.2.3 Europe Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Table 18: Europe Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 50: Europe Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.2.4 U.K. 10.2.4.1 U.K. Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 51: U.K. Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.2.4.2 U.K. Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 52: U.K. Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.2.5 Germany 10.2.5.1 Germany Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 53: Germany Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.2.5.2 Germany Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 54: Germany Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.2.6 France 10.2.6.1 France Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 55: France Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.2.6.2 France Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 56: France Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.2.7 Rest of Europe 10.2.7.1 Rest of Europe Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 57: Rest of Europe Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.2.7.2 Rest of Europe Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 58: Rest of Europe Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.3 Asia Pacific Figure 59: Asia Pacific Sacral Nerve Stimulation Market, By Revenue Forecast (2020-2028) 10.3.1 Asia Pacific Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Table 19: Asia Pacific Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Figure 60: Asia Pacific Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) 10.3.2 Asia Pacific Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Table 20: Asia Pacific Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 61: Asia Pacific Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.3.3 Asia Pacific Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Table 21: Asia Pacific Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 62: Asia Pacific Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.3.4 China 10.3.4.1 China Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 63: China Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.3.4.2 China Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 64: China Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.3.5 India 10.3.5.1 India Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 65: India Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.3.5.2 India Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 66: India Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.3.6 Japan 10.3.6.1 Japan Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 67: Japan Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.3.6.2 Japan Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 68: Japan Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.3.7 South Korea 10.3.7.1 South Korea Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 69: South Korea Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.3.7.2 South Korea Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 70: South Korea Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.3.8 Rest of APAC 10.3.8.1 Rest of APAC Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 71: Rest of APAC Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.3.8.2 Rest of APAC Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 72: Rest of APAC Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.4 Latin America Figure 73: Latin America Sacral Nerve Stimulation Market, By Revenue Forecast (2020-2028) 10.4.1 Latin America Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Table 22: Latin America Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) Figure 74: Latin America Sacral Nerve Stimulation market, by country, 2020 - 2028 (USD Million) 10.4.2 Latin America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Table 23: Latin America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 75: Latin America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.4.3 Latin America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Table 24: Latin America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 76: Latin America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.4.4 Brazil 10.4.4.1 Brazil Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 77: Brazil Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.4.4.2 Brazil Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 78: Brazil Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.4.5 Mexico 10.4.5.1 Mexico Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 79: Mexico Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.4.5 2 Mexico Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 80: Mexico Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.4.6 Rest of the Latin America 10.4.6.1 Rest of the Latin America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 81: Rest of the Latin America Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.4.6.2 Rest of the Latin America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 82: Rest of the Latin America Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) 10.5 MEA Figure 83: MEA Sacral Nerve Stimulation Market, By Revenue Forecast (2020-2028) 10.5.1 MEA Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) Figure 84: MEA Sacral Nerve Stimulation market, By Product, 2020 - 2028 (USD Million) 10.5.2 MEA Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Figure 85: MEA Sacral Nerve Stimulation market, by Application, 2020 - 2028 (USD Million) Chapter 11. Competitive Landscape 11.1 Cyberonics. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Product Portfolio Analysis 11.1.4 Business Strategy & Recent Development 11.2 Codman & Shurtleff. 11.2.1 Company overview 11.2.2 Financial performance 11.2.3 Product Portfolio Analysis 11.2.4 Business Strategy & Recent Development 11.3 Axonics Modulation Technologies. 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Product Portfolio Analysis 11.3.4 Business Strategy & Recent Development 11.4 NeuroPace. 11.4.1 Company overview 11.4.2 Financial performance 11.4.3 Product Portfolio Analysis 11.4.4 Business Strategy & Recent Development 11.5 Medtronic. 11.5.1 Company overview 11.5.2 Financial performance 11.5.3 Product Portfolio Analysis 11.5.4 Business Strategy & Recent Development 11.6 F. Uroplasty. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Product Portfolio Analysis 11.6.4 Business Strategy & Recent Development 11.7 Laborie. 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Product Portfolio Analysis 11.7.4 Business Strategy & Recent Development 11.8 St. Jude Medical. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Product Portfolio Analysis 11.8.4 Business Strategy & Recent Development 11.9 Synapse Biomedical. 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Product Portfolio Analysis 11.9.4 Business Strategy & Recent Development 11.10 IntraPace. 11.10.1 Company overview 11.10.2 Financial performance 11.10.3 Product Portfolio Analysis 11.10.4 Business Strategy & Recent Development